Already a DIA Member? Sign in. Not a member? Join.

Sign in

Forgot User ID? or Forgot Password?

Not a Member?

Create Account and Join

InterContinental San Francisco

Nov 05, 2018 7:00 AM - Nov 06, 2018 3:00 PM

888 Howard Street, San Francisco, CA 94103

Real World Evidence Conference

This conference has reached maximum capacity.

Session 6: Patient Contributed Data

Session Chair(s)

Marni  Hall, PhD, MPH

Marni Hall, PhD, MPH

VP & GM, Global Regulatory Science and Strategy

IQVIA, United States

This session will focus on patient-generated health data (PGHD). Different types of PGHD, such as structured and unstructured forms, and criteria for their use will be discussed. Case studies of assessment and application of use of PGHD for clinical and regulatory decision-making will be shared. Concrete steps for advancing greater use of PGHD will be outlined

Learning Objective : At the conclusion of this session, participants should be able to:
  • Describe different types of PGHD
  • Formulate evaluation method(s) to validate use of PGHD for a specific purpose
  • Identify opportunities for pilot projects to advance the use of PGHD

Speaker(s)

Emily  Drabant Conley, PhD

23andMe: Innovation in Clinical Trial Recruitment: Emily Drabant Conley, PhD

Vice President of Business Development

23andMe, United States

Christine  Lemke

Patient Contributed Data: Christine Lemke

Co-Founder & President

Evidation Heath, Inc., United States

Sally  Okun, BSN, MHS, MBA, RN

Patient Contributed Data: Sally Okun, BSN, MHS, MBA, RN

Executive Director

Clinical Trials Transformation Initiative (CTTI), United States

Have an account?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.